XBiotech(XBIT) - 2022 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________________ FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ Transaction Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission file number 001-37437 ________________________________________________ XBIOTECH INC. (Exact name of Registrant as specified in its charter) British ...